Viewing Study NCT05170594

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-06-06 @ 8:37 PM
Study NCT ID: NCT05170594
Status: UNKNOWN
Last Update Posted: 2021-12-28
First Post: 2021-12-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer
Sponsor: The Second Affiliated Hospital of Shandong First Medical University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None platinum-resistant View
None recurrent ovarian cancer View
None Bevacizumab View
None Fluzoparib View